PD-L1 pathway as a novel target in carcinosarcoma of the kidney and renal pelvis
Carcinosarcoma of the kidney and renal pelvis (CSKP) is a rare and highly-aggressive malignancy characterized by rapid progression and widespread metastases. To date, few studies describe the natural history of the disease. We present a patient placed on pembrolizumab therapy for suspected metastati...
Main Authors: | Ashwin M. Raghavan, Zane C. Giffen, Patrick M. Irwin, Hesham I. Mostafa, Bradley J. Buck |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Urology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214442020301492 |
Similar Items
-
Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
by: Jonathan T. Hunt, et al.
Published: (2021-08-01) -
Gallbladder carcinosarcoma masquerading as a hepatic abscess
by: Ruhaid Khurram, MBBS, et al.
Published: (2021-01-01) -
Sinonasal Teratoid Carcinosarcoma
by: Jose M. Carnate
Published: (2007-11-01) -
Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives
by: Salvatore Giovanni Vitale, et al.
Published: (2017-05-01) -
Carcinosarcoma of the Maxillary Sinus
by: Jeong-Ki Moon, et al.
Published: (2013-06-01)